Discontinuing Treatment in Patients With CML

Chapter 4

In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the reasoning behind treatment discontinutation and discussing the situations where it is appropriate to stop treatment.

Chapter 1

Treatment Options for Patients with CML

In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the tyrosine kinase inhibitors available to treat patients with chronic myeloid leukemia.

Chapter 2

Choosing the Appropriate Tyrosine Kinase Inhibitor

In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses the decision making factors related to selecting a tyrosine kinase inhibitor for individual patients.

Chapter 3

Monitoring Adherence in Patients With CML

In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses the importance of discussing side effects with patients and tracking their adherence to ensure optimal outcomes.

Chapter 5

Managing Adverse Events in Patients With CML

In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, gives an overview of potential adverse events, including cardiovascular events, and provides insight into how they are best managed during the treatment of CML.

Chapter 6

On the Horizon of CML Treatment

In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses important milestones in the treatment of CML on the horizon.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs